Sujit Choudhry and His Work In Comparative Law

Around the year 1748, it is believed that a man by the name of Montesquieu helped to develop the concept of comparative law. Comparative law, by definition, is the comparison of all existing legal systems. In comparative law, the similarities and differences of the legal system of every country and governmental body is studied in depth. This study helps international institutions such as the United Nations to come up with treaties that oblige by the laws of participating countries. Also, it exists to help lawmakers and citizens to understand and perfect their own systems, while coming to an understanding of the legal systems of their counterparts.

In modern comparative law, several different branches have developed. One of the foremost branches is that of comparative constitutional law, which is the study of the different constitutional structures that exist today. There are scores of authorities in the field of comparative constitutional law, but none are as internationally recognized as Professor Sujit Choudhry. Mr. Choudhry works as both the dean and professor of law at the University of California, Berkeley, and holds law degrees from Oxford, Toronto, and Harvard. He also has experience as an advisor to the constitutional building processes of Nepal, Egypt, South Africa, Jordan, Libya, Ukraine, Tunisia, and Sri Lanka.

Professor Sujit Choudhry studies a variety of issues involved in comparative constitutional law, such as using constitutional design as a tool to manage the transition from violent actions to peaceful politics, using constitutional design in ethnically divided societies and constitutional courts, and using constitutional design as a tool in minority rights. Choudhry is very knowledgeable in Canadian constitutional law and has written extensively on the subject. He has also published over ninety articles, working papers and reports, and book chapters.

His work includes more than teaching, researching, and writing, as Professor Choudhry is also a member of a number of boards, including the Editorial Board of the Constitutional Court Review, the Board of Editors of the International Journal of Constitutional Law, the Executive Committee of the International Society of Public Law, and the Editorial Advisory board for the Cambridge Studies in Constitutional Law.

Can Eric Lefkofsky Cure Cancer?

The Man With The Midas Touch

Eric Lefkofsky is one of the world’s most successful businessmen. From his college days onward, just about every startup he creates or invests in has achieved success. Just taking a brief glance at some examples of his startups provides overwhelming evidence of his ingenuity. Groupon, founded in 2010, broke records and reached $1 billion in revenue faster than any other business in history. Similar success stories happened with Lightbank, Brandon Apparel, and so on.

Tackling Real World Issues

Lefkofsky’s entrepreneurship hasn’t blinded him to conditions of those with less than him. Philanthropic work is found throughout his career and he continues to support charitable causes as his fortune grows. Most of his philanthropy centers around the Lefkofsky Family Foundation. Working together with his wife, Lefkofsky uses the foundation to support charities across the world involved in just about every cause imaginable.

Some of the charities work to promote scientific research while others improve conditions in developing countries. The main focus of his charity is on improving the lives of children through better access to education and healthcare. Another area of philanthropy for Lefkofsky is the Giving Pledge. Like many other billionaires such as Bill Gates and Warren Buffet, Lefkofsky has pledged to use his wealth for the improvement of mankind. He has the ability to help others around him and he isn’t afraid to spend millions in the process.

Cancer Is In His Sight

Recently, Lefkofsky decided to merge his entrepreneurship with his philanthropy to start up a new company called Tempus. Centered around the idea of personalized medicine, Tempus uses the genetic profile of patients to come up with therapy plans tailored to each specific patient. With the DNA sequence of each patient in their databases, Tempus can determine exactly how each medication will affect the patient. Certain medications may have unwanted side effects or lower effectiveness depending on the patient’s genetic makeup, but other patients may have genes that work well with that particular plan. Personalized medicine is still in its infancy, but the work of Lefkofsky could bring it into the forefront.

The Future Of Medicine?

Eric Lefkofsky understands how to pick winners in the free market. He is taking this understanding and applying it to the practice of medicine. Medical startups, especially one dealing with something as specific as cancer, usually carry risks with them. However, his approach, using Big Data to find cures, may give us the breakthroughs needed to finally defeat cancer. As a billionaire, he is able to take these sort of risks without worrying because he can protect himself from the potential loss. A big reward always requires a big risk.